Clincosm LogoSign in Get a demo

diabetes mellitus, type 2

Showing NaN - NaN of 79
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Platelet Aggregation, Type 2 Diabetes, Aspirin Trial in Montréal (Aspirin 81Mg Ec Tab twice daily for 7 days, Aspirin 40Mg Chew

Not yet recruiting
  • Platelet Aggregation
  • +4 more
  • Aspirin 81Mg Ec Tab twice daily for 7 days
  • +2 more
  • Montréal, Quebec, Canada
    Montreal Heart Institute
Jan 25, 2023

Diabetes, Type 2, Peripheral Arterial Disease Trial in Worldwide (Semaglutide, Placebo (semaglutide))

Recruiting
  • Diabetes Mellitus, Type 2
  • Peripheral Arterial Disease
  • Birmingham, Alabama
  • +179 more
Jan 23, 2023

Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo (semaglutide))

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Tuscumbia, Alabama
  • +393 more
Jan 17, 2023

Diabetes, Type 2 Trial in Worldwide (Insulin icodec, Placebo insulin icodec, Insulin degludec)

Completed
  • Diabetes Mellitus, Type 2
  • Insulin icodec
  • +3 more
  • Guntersville, Alabama
  • +91 more
Nov 11, 2022

Diabetes, Type 2 Trial in Worldwide (Insulin icodec, Insulin Glargine 100U/mL, Insulin Degludec)

Completed
  • Diabetes Mellitus, Type 2
  • Insulin icodec
  • +3 more
  • Birmingham, Alabama
  • +178 more
Nov 3, 2022

Diabetes, Type 2 Trial in Montréal (Insulin closed-loop)

Completed
  • Diabetes Mellitus, Type 2
  • Insulin closed-loop
  • Montréal, Quebec, Canada
    Centre for Innovative Medicine at McGill University Health Centr
Aug 23, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Little Rock, Arkansas
  • +228 more
Jul 11, 2022

Diabetes, Type 2 Trial in Worldwide (IcoSema, Semaglutide 1 mg)

Recruiting
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +81 more
Jun 28, 2022

Diabetes, Type 2 Trial in Worldwide (Metformin DR, Metformin IR, Metformin DR Placebo)

Recruiting
  • Diabetes Mellitus, Type 2
  • Metformin DR
  • +3 more
  • Glendale, Arizona
  • +86 more
Jun 7, 2022

Bone Health After Bariatric Surgery in Type 2 Diabetes

Recruiting
  • Bariatric Surgery
  • +3 more
  • Bariatric surgery
  • Montréal, Quebec, Canada
  • +2 more
May 31, 2022

Diabetes, Type 2 Trial in Worldwide (Oral semaglutide)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Oral semaglutide
  • Buena Park, California
  • +177 more
Mar 31, 2022

Diabetes, Type 2 Trial in Worldwide (Dapagliflozin, Saxagliptin, Placebo)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Sacramento, California
  • +122 more
Mar 21, 2022

Diabetes, Type 2, Heat Exposure Trial in Montréal (Thermoneutral water, Hot water)

Recruiting
  • Diabetes Mellitus, Type 2
  • Heat Exposure
  • Thermoneutral water
  • Hot water
  • Montréal, Quebec, Canada
    Centre ÉPIC, Montreal Heart Institute
Mar 21, 2022

Diabetes, Type 2 Trial in Worldwide (BI 456906, Placebo, Semaglutide)

Completed
  • Diabetes Mellitus, Type 2
  • BI 456906
  • +2 more
  • Huntington Park, California
  • +79 more
Mar 22, 2022

Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo (semaglutide))

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Montgomery, Alabama
  • +444 more
Mar 11, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (Faster-acting insulin aspart, Insulin aspart, Insulin degludec)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Faster-acting insulin aspart
  • +3 more
  • Concord, California
  • +166 more
Jan 6, 2022

Diabetes, Type 2 Trial in Montréal (Aspirin 80 mg EC Tab)

Recruiting
  • Diabetes Mellitus, Type 2
  • Aspirin 80 mg EC Tab
  • Montréal, Quebec, Canada
    Montreal Heart Institute
Nov 2, 2021

Bone and Muscle Quality and Strength in Obesity With and Without

Completed
  • Diabetes Mellitus
  • +10 more
    • Montréal, Quebec, Canada
    • +1 more
    Aug 30, 2021

    Coronary Arteriosclerosis, Diabetes, Type 2, Cerebrovascular Accident Trial in Worldwide (Atorvastatin (Lipitor))

    Completed
    • Coronary Arteriosclerosis
    • +4 more
    • Atorvastatin (Lipitor)
    • Mississauga, Ontario, Cameroon
    • +120 more
    Feb 17, 2021

    NAFLD, Diabetes, Type 2, Hypertriglyceridemia Trial in Canada, United States (Placebo, ISIS 703802 40 mg, ISIS 703802 80 mg)

    Completed
    Has Results
    • NAFLD
    • +3 more
    • Placebo
    • +3 more
    • Chandler, Arizona
    • +41 more
    Jan 28, 2021

    Diabetes, Type 2 Trial in Worldwide (Insulin degludec, Insulin glargine)

    Completed
    Has Results
    • Diabetes Mellitus, Type 2
    • Insulin degludec
    • Insulin glargine
    • Chandler, Arizona
    • +66 more
    Dec 16, 2020

    Sodium-glucose Cotransporter 2 Inhibitors Among Type 2 Diabetes

    Completed
    • Diabetes Mellitus, Type 2
    • +3 more
    • Sodium-glucose cotransporter 2 (SGLT2) inhibitors
    • +2 more
    • Montreal, Quebec, Canada
      Lady Davis Institute for Medical Research, Jewish General Hospit
    Aug 17, 2020

    Diabetes, Type 2 Trial in Worldwide (MEDI0382 low dose, MEDI0382 mid dose, MEDI0382 high dose)

    Completed
    Has Results
    • Diabetes Mellitus, Type 2
    • MEDI0382 low dose
    • +4 more
    • Birmingham, Alabama
    • +118 more
    Jul 31, 2020

    Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine)

    Completed
    Has Results
    • Diabetes
    • Diabetes Mellitus, Type 2
    • insulin degludec/liraglutide
    • insulin glargine
    • Glendale, Arizona
    • +87 more
    Aug 10, 2020

    Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, alpha-glucosidase inhibitors, DPP-4 inhibitors)

    Completed
    Has Results
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Birmingham, Alabama
    • +231 more
    Jun 16, 2020